Page last updated: 2024-09-04

cositecan and Cancer of Head

cositecan has been researched along with Cancer of Head in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Azrak, RG; Frank, C; Guo, B; Minderman, H; Rustum, YM; Slocum, HK; Vanhoefer, U; Wrzosek, C; Yin, MB	1

Other Studies

1 other study(ies) available for cositecan and Cancer of Head

Article	Year
Characterization of protein kinase chk1 essential for the cell cycle checkpoint after exposure of human head and neck carcinoma A253 cells to a novel topoisomerase I inhibitor BNP1350. Molecular pharmacology, 2000, Volume: 57, Issue:3 Topics: Camptothecin; CDC2 Protein Kinase; Cell Cycle; Cell Cycle Proteins; Cell Division; Checkpoint Kinase 1; Cyclin B; DNA Fragmentation; DNA Topoisomerases, Type I; Electrophoresis, Gel, Pulsed-Field; Head and Neck Neoplasms; Humans; Phosphorylation; Protein Kinases; Topoisomerase I Inhibitors; Tumor Cells, Cultured	2000

Article

Year

Characterization of protein kinase chk1 essential for the cell cycle checkpoint after exposure of human head and neck carcinoma A253 cells to a novel topoisomerase I inhibitor BNP1350.

Molecular pharmacology, 2000, Volume: 57, Issue:3

Topics: Camptothecin; CDC2 Protein Kinase; Cell Cycle; Cell Cycle Proteins; Cell Division; Checkpoint Kinase 1; Cyclin B; DNA Fragmentation; DNA Topoisomerases, Type I; Electrophoresis, Gel, Pulsed-Field; Head and Neck Neoplasms; Humans; Phosphorylation; Protein Kinases; Topoisomerase I Inhibitors; Tumor Cells, Cultured

2000